Recor Medical, Inc.

- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.recormedical.com
Clinical Trials
8
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)β’ Click on a phase to view related trials
Global Paradise System US Post Approval Study
- Conditions
- HypertensionVascular DiseasesCardiovascular Diseases
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- ReCor Medical, Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT06297291
- Locations
- πΊπΈ
Sutter Institute for Medical Research, Sacramento, California, United States
πΊπΈRocky Mountain Regional VAMC, Aurora, Colorado, United States
πΊπΈBridgeport Hosptial, Bridgeport, Connecticut, United States
The "Global Paradise System" Registry
- Conditions
- Hypertension
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- ReCor Medical, Inc.
- Target Recruit Count
- 3000
- Registration Number
- NCT05027685
- Locations
- π§πͺ
OLV Ziekenhuis Aalst, Aalst, Belgium
π§πͺCHU Saint Pierre Brussels, Brussel, Belgium
π§πͺUCL St Luc, Brussel, Belgium
RADIANCE Continued Access Protocol
- Conditions
- HypertensionVascular DiseasesHypertension, Resistant to Conventional TherapyCardiovascular Diseases
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- ReCor Medical, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT05017935
- Locations
- πΊπΈ
Cardiovascular Institute of San Diego, Chula Vista, California, United States
πΊπΈCedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈSutter Health, Sacramento, California, United States
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
- Conditions
- Cardiovascular DiseasesVascular DiseasesHypertension
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- ReCor Medical, Inc.
- Target Recruit Count
- 225
- Registration Number
- NCT03614260
- Locations
- πΊπΈ
Cardiology PC, Birmingham, Alabama, United States
πΊπΈCedars Sinai Medical Center, Los Angeles, California, United States
πΊπΈBridgeport Hospital, Bridgeport, Connecticut, United States
A Study of the ReCor Medical Paradise System in Clinical Hypertension
- Conditions
- Vascular DiseasesHypertension
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- ReCor Medical, Inc.
- Target Recruit Count
- 282
- Registration Number
- NCT02649426
- Locations
- πΊπΈ
University of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈCedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈSutter Health Medical Center, Sacramento, California, United States
- Prev
- 1
- 2
- Next